O88839 (ADA15_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 144.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Disintegrin and metalloproteinase domain-containing protein 15 Short name=ADAM 15 EC=3.4.24.- Alternative name(s): AD56 Metalloprotease RGD disintegrin protein Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15 Short name=MDC-15 Metargidin | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 864 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Active metalloproteinase with gelatinolytic and collagenolytic activity. Plays a role in the wound healing process. Mediates both heterotypic intraepithelial cell/T-cell interactions and homotypic T-cell aggregation. Inhibits beta-1 integrin-mediated cell adhesion and migration of airway smooth muscle cells. Suppresses cell motility on or towards fibronectin possibly by driving alpha-v/beta-1 integrin (ITAGV-ITGB1) cell surface expression via ERK1/2 inactivation. Cleaves E-cadherin in response to growth factor deprivation. Plays a role in glomerular cell migration By similarity. Plays a role in pathological neovascularization. May play a role in cartilage remodeling. May be proteolytically processed, during sperm epididymal maturation and the acrosome reaction. May play a role in sperm-egg binding through its disintegrin domain. Interactions with egg membrane could be mediated via binding between the disintegrin-like domain to one or more integrin receptors on the egg. Ref.5 Ref.7 Ref.8 Ref.9 |
| Cofactor | Binds 1 zinc ion per subunit Potential. |
| Subunit structure | Interacts specifically with Src family protein-tyrosine kinases (PTKs) By similarity. Interacts with ITAGV-ITGB3 (vitronectin receptor). Interacts with SH3GL2 and SNX9; this interaction occurs preferentially with ADAM15 precursor, rather than the processed form, suggesting it occurs in a secretory pathway compartment prior to the medial Golgi. Interacts with ITAG9-ITGB1. Interacts with SH3PXD2A By similarity. Interacts with ITAGV-ITGB1. Interacts with GRB2, HCK, ITSN1, ITSN2, LYN, MAPK1, MAPK3, NCF1, NCK1, nephrocystin, PTK6, SNX33, LCK and SRC By similarity. Ref.6 Ref.7 |
| Subcellular location | Endomembrane system; Single-pass type I membrane protein. Cell junction › adherens junction By similarity. Cell projection › cilium › flagellum. Cytoplasmic vesicle › secretory vesicle › acrosome. Note: The majority of the protein is localized in a perinuclear compartment which may correspond to the trans-Golgi network or the late endosome. The pro-protein is the major detectable form on the cell surface, whereas the majority of the protein in the cell is processed. Ref.5 |
| Tissue specificity | Expressed moderately in pericytes of retina. Expressed in testis and in spermatozoa from the caput, corpus, and cauda epididymis, as well as in non-capacitated and acrosome-reacted sperm (at protein level). Highly expressed in heart, brain, lung, and kidney. Expressed at lower levels in spleen, liver, testis and muscle. Ref.5 Ref.10 |
| Developmental stage | At E13.5, strongly expressed in the developing vasculature of the endocardium. At P17, expressed throughout the retina (at protein level). At E9.5 and thereafter, prominently expressed in the vasculature, including in ventral and dorsal aorta and the caudal artery. In developing heart, detected in endocardium and blood vessels of the ventricle, bulbus arteriosus, and atrium. Also highly expressed in hypertrophic cells of the developing bone. In adult, expressed prominently in brain, including in hippocampus, cerebellum, pons, thalamus, cortex, and olfactory bulb. Ref.8 Ref.10 |
| Induction | By hypoxic stimulus in retina (at protein level). Up-regulated by VEGF in retina. Ref.8 Ref.10 |
| Domain | The cytoplasmic domain is required for SH3GL2- and SNX9-binding. Disintegrin domain binds to integrin alphaV-beta3 By similarity. The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme. |
| Post-translational modification | The precursor is cleaved by a furin endopeptidase. An additional membrane proximal site of cleavage affects a small percentage of the proteins and results in disulfide-linked fragments. The prodomain is apparently cleaved in several positions that are N-terminal of the furin cleavage site. Ref.1 May be partially sialylated. Phosphorylation increases association with PTKs By similarity. |
| Miscellaneous | Mice targeted for deletion of the first 27 amino acids of the ADAM15 N-terminal sequence are viable and fertile, showing no major developmental defects and displaying normal mortality or morbidity. These mutant mice, however, exhibit significantly reduced ischemia-induced retinal neovascularization, choroidal neovascularization at rupture sites in Bruch's membrane, and VEGF-induced subretinal neovascularization, and develop significantly smaller tumors following implantation of B16F0 melanoma cells. Aging mutant mice exhibit accelerated development of osteoarthritic lesions in knee joints. |
| Sequence similarities | Contains 1 disintegrin domain. Contains 1 EGF-like domain. Contains 1 peptidase M12B domain. |
Ontologies
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O88839-1) Also known as: ADAM15v2; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O88839-2) Also known as: ADAM15v1; The sequence of this isoform differs from the canonical sequence as follows: 761-785: Missing. | ||||||
| Isoform 3 (identifier: O88839-3) Also known as: ADAM15; The sequence of this isoform differs from the canonical sequence as follows: 761-809: Missing. | ||||||
| Isoform 4 (identifier: O88839-4) The sequence of this isoform differs from the canonical sequence as follows: 415-830: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 17 | 17 | Potential | ||||||||
| Propeptide | 18 – 207 | 190 | Probable | PRO_0000029084 | |||||||
| Chain | 208 – 864 | 657 | Disintegrin and metalloproteinase domain-containing protein 15 | PRO_0000029085 | |||||||
Regions | |||||||||||
| Topological domain | 208 – 696 | 489 | Extracellular Potential | ||||||||
| Transmembrane | 697 – 717 | 21 | Helical; Potential | ||||||||
| Topological domain | 718 – 864 | 147 | Cytoplasmic Potential | ||||||||
| Domain | 214 – 415 | 202 | Peptidase M12B | ||||||||
| Domain | 422 – 509 | 88 | Disintegrin | ||||||||
| Domain | 658 – 686 | 29 | EGF-like | ||||||||
| Motif | 177 – 184 | 8 | Cysteine switch By similarity | ||||||||
| Motif | 816 – 822 | 7 | SH3-binding Potential | ||||||||
| Motif | 851 – 857 | 7 | SH3-binding Potential | ||||||||
| Compositional bias | 510 – 657 | 148 | Cys-rich | ||||||||
| Compositional bias | 699 – 712 | 14 | Poly-Leu | ||||||||
Sites | |||||||||||
| Active site | 350 | 1 | Potential | ||||||||
| Metal binding | 179 | 1 | Zinc; in inhibited form By similarity | ||||||||
| Metal binding | 349 | 1 | Zinc; catalytic Potential | ||||||||
| Metal binding | 353 | 1 | Zinc; catalytic Potential | ||||||||
| Metal binding | 359 | 1 | Zinc; catalytic Potential | ||||||||
| Site | 289 – 290 | 2 | Cleavage; by furin Potential | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 716 | 1 | Phosphotyrosine; by HCK and LCK By similarity | ||||||||
| Modified residue | 736 | 1 | Phosphotyrosine; by HCK and LCK By similarity | ||||||||
| Glycosylation | 238 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 390 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 393 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 607 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 612 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 324 ↔ 410 | By similarity | |||||||||
| Disulfide bond | 366 ↔ 394 | By similarity | |||||||||
| Disulfide bond | 368 ↔ 377 | By similarity | |||||||||
| Disulfide bond | 481 ↔ 501 | By similarity | |||||||||
| Disulfide bond | 658 ↔ 668 | By similarity | |||||||||
| Disulfide bond | 662 ↔ 674 | By similarity | |||||||||
| Disulfide bond | 676 ↔ 685 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 415 – 830 | 416 | Missing in isoform 4. | VSP_008879 | |||||||
| Alternative sequence | 761 – 809 | 49 | Missing in isoform 3. | VSP_008881 | |||||||
| Alternative sequence | 761 – 785 | 25 | Missing in isoform 2. | VSP_008880 | |||||||
Experimental info | |||||||||||
| Mutagenesis | 482 | 1 | R → A: Reduced binding to CHO cells expressing ITAG9-ITGB1. Ref.7 | ||||||||
| Mutagenesis | 489 | 1 | D → A: Reduced binding to CHO cells expressing ITAG9-ITGB1. Ref.7 | ||||||||
| Mutagenesis | 490 | 1 | L → A: Reduced binding to CHO cells expressing ITAG9-ITGB1. Ref.7 | ||||||||
| Mutagenesis | 491 | 1 | P → A: Reduced binding to CHO cells expressing ITAG9-ITGB1. Ref.7 | ||||||||
| Mutagenesis | 492 | 1 | E → A: Reduced binding to CHO cells expressing ITAG9-ITGB1. Ref.7 | ||||||||
| Mutagenesis | 493 | 1 | F → A: Reduced binding to CHO cells expressing ITAG9-ITGB1. Ref.7 | ||||||||
| Sequence conflict | 21 – 22 | 2 | PP → RR in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 51 | 1 | Q → H in BAE29090. Ref.3 | ||||||||
| Sequence conflict | 73 | 1 | S → P in BAE41564. Ref.3 | ||||||||
| Sequence conflict | 443 | 1 | E → Q in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 459 | 1 | G → E in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 564 – 565 | 2 | SP → T in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 654 | 1 | G → E in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 660 | 1 | R → S in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 703 | 1 | L → R in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 712 | 1 | L → R in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 729 | 1 | L → R in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 830 | 1 | Q → R in BAE41564. Ref.3 | ||||||||
| Sequence conflict | 846 | 1 | L → S in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 852 – 854 | 3 | PAP → AAS in BAA88903. Ref.2 | ||||||||
| Sequence conflict | 859 | 1 | A → P in BAA88903. Ref.2 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Intracellular maturation of the mouse metalloprotease disintegrin MDC15." Lum L., Reid M.S., Blobel C.P. J. Biol. Chem. 273:26236-26247(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), PROTEOLYTIC PROCESSING. Tissue: Lung. |
| [2] | "Structure and expression of the murine ADAM 15 gene and its splice variants, and difference of interaction between their cytoplasmic domains and Src family proteins." Shimizu E., Yasui A., Matsuura K., Hijiya N., Higuchi Y., Yamamoto S. Biochem. Biophys. Res. Commun. 309:779-785(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3). Tissue: Myeloid and Myeloma. |
| [3] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3). Strain: C57BL/6J and NOD. Tissue: Bone marrow macrophage, Cerebellum and Dendritic cell. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Mammary gland. |
| [5] | "Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding." Pasten-Hidalgo K., Hernandez-Rivas R., Roa-Espitia A.L., Sanchez-Gutierrez M., Martinez-Perez F., Monrroy A.O., Hernandez-Gonzalez E.O., Mujica A. Reproduction 136:41-51(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 207-694 (ISOFORMS 1/2/3), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Testis. |
| [6] | "Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1." Howard L., Nelson K.K., Maciewicz R.A., Blobel C.P. J. Biol. Chem. 274:31693-31699(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ENDOPHILIN I AND SNX9. |
| [7] | "Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions." Eto K., Huet C., Tarui T., Kupriyanov S., Liu H.Z., Puzon-McLaughlin W., Zhang X.P., Sheppard D., Engvall E., Takada Y. J. Biol. Chem. 277:17804-17810(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH INTEGRIN ALPHAV-BETA3 AND ALPHA9-BETA1, MUTAGENESIS OF ARG-482; ASP-489; LEU-490; PRO-491; GLU-492 AND PHE-493. |
| [8] | "Potential role for ADAM15 in pathological neovascularization in mice." Horiuchi K., Weskamp G., Lum L., Hammes H.P., Cai H., Brodie T.A., Ludwig T., Chiusaroli R., Baron R., Preissner K.T., Manova K., Blobel C.P. Mol. Cell. Biol. 23:5614-5624(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DEVELOPMENTAL STAGE, INDUCTION. |
| [9] | "Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling." Bohm B.B., Aigner T., Roy B., Brodie T.A., Blobel C.P., Burkhardt H. Arthritis Rheum. 52:1100-1109(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization." Xie B., Shen J., Dong A., Swaim M., Hackett S.F., Wyder L., Worpenberg S., Barbieri S., Campochiaro P.A. FASEB J. 22:2775-2783(2008) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, INDUCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF006196 mRNA. Translation: AAC61896.1. AB022089 Genomic DNA. Translation: BAA88903.1. AK048901 mRNA. Translation: BAC33485.1. AK149796 mRNA. Translation: BAE29090.1. AK151804 mRNA. Translation: BAE30703.1. AK152725 mRNA. Translation: BAE31447.1. AK170101 mRNA. Translation: BAE41564.1. BC009132 mRNA. Translation: AAH09132.1. EF506571 mRNA. Translation: ABP73662.1. |
| IPI | IPI00123329. IPI00135185. IPI00378498. IPI00395062. |
| RefSeq | NP_001032811.2. NM_001037722.2. NP_033744.1. NM_009614.2. |
| UniGene | Mm.274049. |
3D structure databases | |
| ProteinModelPortal | O88839. |
| SMR | O88839. Positions 208-688. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O88839. 2 interactions. |
| MINT | MINT-4996290. |
Protein family/group databases | |
| MEROPS | M12.215. |
PTM databases | |
| PhosphoSite | O88839. |
Proteomic databases | |
| PaxDb | O88839. |
| PRIDE | O88839. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000029676; ENSMUSP00000029676; ENSMUSG00000028041. ENSMUST00000074582; ENSMUSP00000074167; ENSMUSG00000028041. ENSMUST00000107446; ENSMUSP00000103070; ENSMUSG00000028041. ENSMUST00000107448; ENSMUSP00000103072; ENSMUSG00000028041. |
| GeneID | 11490. |
| KEGG | mmu:11490. |
| UCSC | uc008pyv.1. mouse. uc008pyw.1. mouse. |
Organism-specific databases | |
| CTD | 8751. |
| MGI | MGI:1333882. Adam15. |
Phylogenomic databases | |
| eggNOG | NOG294463. |
| GeneTree | ENSGT00660000095090. |
| HOVERGEN | HBG006978. |
| InParanoid | Q3UE21. |
| KO | K06836. |
| OMA | GAQCASD. |
| OrthoDB | EOG479F6Q. |
Gene expression databases | |
| ArrayExpress | O88839. |
| Bgee | O88839. |
| Genevestigator | O88839. |
| GermOnline | ENSMUSG00000028041. Mus musculus. |
Family and domain databases | |
| Gene3D | 3.40.390.10. 1 hit. 4.10.70.10. 1 hit. |
| InterPro | IPR006586. ADAM_Cys-rich. IPR001762. Blood-coag_inhib_Disintegrin. IPR000742. EG-like_dom. IPR013032. EGF-like_CS. IPR024079. MetalloPept_cat_dom. IPR001590. Peptidase_M12B. IPR002870. Peptidase_M12B_N. [Graphical view] |
| Pfam | PF08516. ADAM_CR. 1 hit. PF00200. Disintegrin. 1 hit. PF01562. Pep_M12B_propep. 1 hit. PF01421. Reprolysin. 1 hit. [Graphical view] |
| SMART | SM00608. ACR. 1 hit. SM00050. DISIN. 1 hit. SM00181. EGF. 1 hit. [Graphical view] |
| SUPFAM | SSF57552. Disintegrin. 1 hit. |
| PROSITE | PS50215. ADAM_MEPRO. 1 hit. PS00546. CYSTEINE_SWITCH. False negative. PS00427. DISINTEGRIN_1. False negative. PS50214. DISINTEGRIN_2. 1 hit. PS00022. EGF_1. False negative. PS01186. EGF_2. 1 hit. PS50026. EGF_3. 1 hit. PS00142. ZINC_PROTEASE. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 278860. |
| SOURCE | Search... |
Entry information
| Entry name | ADA15_MOUSE | ||||||||
| Accession | Primary (citable) accession number: O88839 Secondary accession number(s): A4ZYV2 Q9QYL2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
